dipalmitoylphosphatidic acid has been researched along with Angiogenesis, Pathologic in 3 studies
dipalmitoylphosphatidic acid: RN given refers to parent cpd without isomeric designation
dihexadecanoyl phosphatidic acid : A phosphatidic acid in which the phosphatidyl acyl groups are both palmitoyl (hexadecanoyl).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J | 1 |
| Zhou, Z | 1 |
| Yao, Y | 1 |
| Dai, J | 1 |
| Zhou, D | 1 |
| Wang, L | 1 |
| Zhang, QQ | 1 |
| Kondo, M | 2 |
| Asai, T | 2 |
| Katanasaka, Y | 1 |
| Sadzuka, Y | 1 |
| Tsukada, H | 1 |
| Ogino, K | 2 |
| Taki, T | 2 |
| Baba, K | 1 |
| Oku, N | 2 |
| Shimizu, K | 1 |
| Kuromi, K | 1 |
| Watanabe, K | 1 |
| Shuto, S | 1 |
| Matsuda, A | 1 |
3 other studies available for dipalmitoylphosphatidic acid and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Dipalmitoylphosphatidic acid inhibits breast cancer growth by suppressing angiogenesis via inhibition of the CUX1/FGF1/HGF signalling pathway.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chick Embryo; C | 2018 |
Anti-neovascular therapy by liposomal drug targeted to membrane type-1 matrix metalloproteinase.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides | 2004 |
Anti-neovascular therapy by liposomal DPP-CNDAC targeted to angiogenic vessels.
Topics: Amino Acid Sequence; Angiogenesis Inhibitors; Animals; Cytarabine; Drug Delivery Systems; Liposomes; | 2002 |